Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Nektar Therapeutics (NKTR)

2014-09-17@12:41:30 ET
Nektar Therapeutics (NKTR) Trading Near $12.63 Support Level (FBM)

2014-09-16@16:26:09 ET
Nektar Therapeutics (NKTR) Showing Bullish Technicals With Resistance At $14.41 (FBM)

2014-09-16@14:26:32 ET
Sellers Reduce Exposure to Shares of Nektar Therapeutics on 2.0x Above-Average Volume (NKTR) (F82)

2014-09-16@12:32:00 ET
FDA Approves MOVANTIK(TM) (naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain (PRN)

2014-09-16@08:29:00 ET
Short-term Underperformance Detected in Shares of Jazz Pharmaceuticals in the Pharmaceuticals Industry (JAZZ, AKRX, AUXL, NKTR, DEPO) (F70)

2014-09-15@12:06:18 ET
Nektar Therapeutics Shares Sinking Lower, Down 2.3% (F77)

2014-09-12@10:27:29 ET
Nektar Therapeutics (NKTR) Showing Resistance Near $14.31 (FBM)

2014-09-12@08:21:08 ET
Repros Therapeutics has Relatively Underperformed its Peers in the Pharmaceuticals Industry (RPRX, JAZZ, NKTR, MRK, AZN) (F70)

2014-07-22@18:46:00 ET
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets (PRN)

2014-07-22@13:06:59 ET
Potential Nektar Therapeutics (NKTR) Trade Targets 10.43% Return (FBM)

2014-07-22@08:53:33 ET
Analysis of Relative Performance in the Pharmaceuticals Industry for Shares of Perrigo (PRGO, NKTR, AVNR, SLXP, PFE) (F70)

2014-07-21@11:55:42 ET
Nektar Therapeutics Makes a Move: Down 2.2% (F77)

2014-07-18@08:55:19 ET
Nektar Therapeutics had the Lowest Relative Performance in the Pharmaceuticals Industry (NKTR, POZN, AUXL, AVNR, MDCO) (F70)

2014-07-17@08:50:35 ET
Nektar Therapeutics (NKTR) Showing Bearish Technicals With Resistance At $12.30 (FBM)